Natasha Pratt, PhD

Master Epidemiologist
U.S. Food and Drug Administration

Poster(s):

• (119) Performance of the US Food and Drug Administration’s COVID-19 Disease Severity Categorization for Use in Real-World Data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (231) Characterizing inpatient electronic health records (EHR) from a large hospital network for use in neonatal pharmacoepidemiology studies in the United States
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (ASPOT01) Validity of the ICD-10-CM diagnosis code to identify patients with COVID-19 in Medicare administrative claims data
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST